The global hair growth supplement and treatment market size was estimated at around USD 7.76 billion in 2023 and it is projected to hit around USD 14.11 billion by 2032, growing at a CAGR of 6.16% from 2024 to 2033. The global hair growth supplement and treatment market is experiencing a significant upswing, fueled by a growing consumer emphasis on hair health and aesthetics. This market's expansion is propelled by a myriad of factors, including increasing concerns about hair-related issues, a rising aging population, and elevated disposable incomes worldwide.
The growth of the hair growth supplement and treatment market can be attributed to several key factors. Firstly, the increasing prevalence of hair-related issues, including hair loss and thinning, has heightened consumer awareness, driving the demand for effective supplements and treatments. Additionally, advancements in technology and research have led to the development of innovative products with scientifically-backed ingredients, enhancing their efficacy. Rising disposable incomes and a growing aging population have further fueled market growth, enabling consumers to invest in premium hair care solutions. Moreover, the market's inclusivity, catering to both men and women, has expanded its consumer base. The trend towards customization and personalization, tailoring products to individual needs, has also played a pivotal role. Furthermore, stringent regulatory compliance and a focus on consumer education have bolstered consumer trust, encouraging increased adoption of hair growth supplements and treatments. These factors combined are propelling the market's continuous expansion, offering promising opportunities for businesses in the industry.
Report Coverage | Details |
Market Revenue by 2033 | USD 14.11 billion |
Growth Rate from 2024 to 2033 | CAGR of 6.16% |
Revenue Share of Asia Pacific in 2023 | 46% |
CAGR of Europe from 2024 to 2033 | 5.43% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units)Companies Covered |
The pharmaceutical segment held the largest revenue share of 89% in 2023. Pharmaceuticals within this segment often consist of medications and treatments that require prescriptions from healthcare professionals. These pharmaceutical solutions are formulated with potent active ingredients, designed to tackle underlying causes of hair loss, such as hormonal imbalances or genetic predispositions. The development of advanced pharmaceuticals represents a crucial aspect of the market, with continuous research leading to the creation of more effective and targeted treatments.
The supplements segment is anticipated to grow at the fastest CAGR of 14.84% over the forecast period. The supplements in the Hair Growth Supplement and Treatment market have gained immense popularity among consumers seeking non-invasive and natural alternatives. These supplements typically contain vitamins, minerals, and herbal extracts known to support hair health. Consumers are drawn to supplements due to their convenience, as they can be easily incorporated into daily routines. Furthermore, the rise in demand for natural and organic products has spurred the development of supplements made from plant-based ingredients, appealing to health-conscious consumers.
The Asia Pacific region dominated the market with a revenue share of 46% in 2023. Asia-Pacific stands out as a dynamic and rapidly growing market for hair growth supplements and treatments. Countries like China, Japan, India, and South Korea are witnessing a surge in demand driven by changing lifestyles, rising disposable incomes, and a booming e-commerce industry. In this region, traditional herbal remedies are often incorporated into supplements, appealing to consumers who value natural and holistic approaches to healthcare. Furthermore, the influence of social media and celebrity endorsements plays a significant role in shaping consumer perceptions and preferences in the Asia-Pacific market.
Europe is anticipated to grow at a CAGR of 5.43% over the forecast period. In Europe, countries like the United Kingdom, Germany, and France are witnessing a steady growth in the hair growth supplement and treatment market. European consumers are inclined towards scientifically-backed products, and there is a strong focus on research and development, leading to innovative formulations. Additionally, the region's population, especially in Western Europe, is aging, contributing to the market's expansion as the elderly demographic often seeks hair growth solutions.
By Type
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Hair Growth Supplement And Treatment Market
5.1. COVID-19 Landscape: Hair Growth Supplement And Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Hair Growth Supplement And Treatment Market, By Type
8.1.Hair Growth Supplement And Treatment Market, by Type, 2024-2033
8.1.1. Supplements
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Hypermarkets/Supermarkets
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Pharmaceuticals
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Devices
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Hair Growth Supplement And Treatment Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2021-2033)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Type (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Type (2021-2033)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Type (2021-2033)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Type (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2021-2033)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Type (2021-2033)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Type (2021-2033)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Type (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2021-2033)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Type (2021-2033)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Type (2021-2033)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Type (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2021-2033)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Type (2021-2033)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Type (2021-2033)
Chapter 10. Company Profiles
10.1. Nutraceutical Wellness Inc. (Unilever)
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Viviscal Limited (Church & Dwight)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Amway
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. GNC Holdings, Inc. (Harbin Pharmaceutical Group)
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. OUAI HAIRCARE (P&G)
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. InVite Health
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson Services, Inc
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Merck & Co., Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3.Financial Performance
10.8.4. Recent Initiatives
10.9. Curallux, LLC.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. iRestore Hair Growth System
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms